A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Regulatory actions for Feb. 9, 2026
Regulatory actions for Feb. 9, 2026
Innovent-Lilly $8.5B deal signals new China inflection point
Innovent-Lilly $8.5B deal signals new China inflection point
Biggest gainers and losers for Feb. 2-6, 2026
Biggest gainers and losers for Feb. 2-6, 2026
Venenum Biodesign discloses new MOGAT2 inhibitors
Venenum Biodesign discloses new MOGAT2 inhibitors
Korean researchers report new HER1/HER2 mutant inhibitors
Korean researchers report new HER1/HER2 mutant inhibitors
Hansoh Pharma and Hansoh Bio synthesize new muscarinic M4 receptor agonists
Hansoh Pharma and Hansoh Bio synthesize new muscarinic M4 receptor agonists
Idorsia gets FDA-backed route to approval for oral Fabry drug
Idorsia gets FDA-backed route to approval for oral Fabry drug
More biopharma IPOs: Agomab raises $200M, Spyglass gets $150M
More biopharma IPOs: Agomab raises $200M, Spyglass gets $150M
Bayer’s asundexian cuts stroke risk 26% in phase III win
Bayer’s asundexian cuts stroke risk 26% in phase III win
Money raised by biopharma
Money raised by biopharma
Biopharma money raised: Jan. 1-Feb. 5, 2026
Biopharma money raised: Jan. 1-Feb. 5, 2026
BioWorld and Nasdaq stock indices
BioWorld and Nasdaq stock indices
Biopharma money raised by month in 2026 (US$M)
Biopharma money raised by month in 2026 (US$M)
Trump’s drug-discount website goes live
Trump’s drug-discount website goes live
ALTx formed to drug pathway by which cancer cells become immortal
ALTx formed to drug pathway by which cancer cells become immortal
O-GlcNAcase inhibitors reported in Tyk Medicines patent
O-GlcNAcase inhibitors reported in Tyk Medicines patent
Abbisko Therapeutics identifies GTPase KRAS mutant inhibitors
Abbisko Therapeutics identifies GTPase KRAS mutant inhibitors
Shenzhen Salubris Pharmaceuticals synthesizes dual PCSK9/HMG-CoA reductase inhibitors
Shenzhen Salubris Pharmaceuticals synthesizes dual PCSK9/HMG-CoA reductase inhibitors
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page